The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global API CDMO+CMC Service Platform Market Research Report 2025

Global API CDMO+CMC Service Platform Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1907463

No of Pages : 87

Synopsis
The API CDMO+CMC service platform refers to a comprehensive platform that provides pharmaceutical companies with API development and manufacturing services. CDMO stands for Contract Development and Manufacturing Organization (Contract Development and Manufacturing Organization), and CMC stands for Chemistry, Manufacturing, and Controls (Chemistry, Manufacturing, and Controls). manufacturing and control). These platforms cover the entire process from new drug development to commercial production, providing pharmaceutical companies with a package of solutions to help them improve efficiency, reduce costs, and accelerate product launches.
The global API CDMO+CMC Service Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for API CDMO+CMC Service Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for API CDMO+CMC Service Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for API CDMO+CMC Service Platform in New Drug Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of API CDMO+CMC Service Platform include Lonza Group, Catalent, Inc., Thermo Fisher Scientific, Pfizer CentreOne, CordenPharma International, Boehringer Ingelheim BioXcellence, Recipharm AB, Changsha Jingyi Pharmaceutical Technology Co., Ltd. and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for API CDMO+CMC Service Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding API CDMO+CMC Service Platform.
Report Scope
The API CDMO+CMC Service Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global API CDMO+CMC Service Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the API CDMO+CMC Service Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza Group
Catalent, Inc.
Thermo Fisher Scientific
Pfizer CentreOne
CordenPharma International
Boehringer Ingelheim BioXcellence
Recipharm AB
Changsha Jingyi Pharmaceutical Technology Co., Ltd.
GlaxoSmithKline
Samsung BioLogics
Emergent BioSolutions
Segment by Type
Comprehensive CDMO Platform
Professional CDMO Platform
International CDMO Platform
Segment by Application
New Drug Development
Clinical Stage Production
Commercial Production
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of API CDMO+CMC Service Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global API CDMO+CMC Service Platform Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Comprehensive CDMO Platform
1.2.3 Professional CDMO Platform
1.2.4 International CDMO Platform
1.3 Market by Application
1.3.1 Global API CDMO+CMC Service Platform Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 New Drug Development
1.3.3 Clinical Stage Production
1.3.4 Commercial Production
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global API CDMO+CMC Service Platform Market Perspective (2019-2030)
2.2 API CDMO+CMC Service Platform Growth Trends by Region
2.2.1 Global API CDMO+CMC Service Platform Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 API CDMO+CMC Service Platform Historic Market Size by Region (2019-2024)
2.2.3 API CDMO+CMC Service Platform Forecasted Market Size by Region (2025-2030)
2.3 API CDMO+CMC Service Platform Market Dynamics
2.3.1 API CDMO+CMC Service Platform Industry Trends
2.3.2 API CDMO+CMC Service Platform Market Drivers
2.3.3 API CDMO+CMC Service Platform Market Challenges
2.3.4 API CDMO+CMC Service Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top API CDMO+CMC Service Platform Players by Revenue
3.1.1 Global Top API CDMO+CMC Service Platform Players by Revenue (2019-2024)
3.1.2 Global API CDMO+CMC Service Platform Revenue Market Share by Players (2019-2024)
3.2 Global API CDMO+CMC Service Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by API CDMO+CMC Service Platform Revenue
3.4 Global API CDMO+CMC Service Platform Market Concentration Ratio
3.4.1 Global API CDMO+CMC Service Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by API CDMO+CMC Service Platform Revenue in 2023
3.5 API CDMO+CMC Service Platform Key Players Head office and Area Served
3.6 Key Players API CDMO+CMC Service Platform Product Solution and Service
3.7 Date of Enter into API CDMO+CMC Service Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 API CDMO+CMC Service Platform Breakdown Data by Type
4.1 Global API CDMO+CMC Service Platform Historic Market Size by Type (2019-2024)
4.2 Global API CDMO+CMC Service Platform Forecasted Market Size by Type (2025-2030)
5 API CDMO+CMC Service Platform Breakdown Data by Application
5.1 Global API CDMO+CMC Service Platform Historic Market Size by Application (2019-2024)
5.2 Global API CDMO+CMC Service Platform Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America API CDMO+CMC Service Platform Market Size (2019-2030)
6.2 North America API CDMO+CMC Service Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America API CDMO+CMC Service Platform Market Size by Country (2019-2024)
6.4 North America API CDMO+CMC Service Platform Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe API CDMO+CMC Service Platform Market Size (2019-2030)
7.2 Europe API CDMO+CMC Service Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe API CDMO+CMC Service Platform Market Size by Country (2019-2024)
7.4 Europe API CDMO+CMC Service Platform Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific API CDMO+CMC Service Platform Market Size (2019-2030)
8.2 Asia-Pacific API CDMO+CMC Service Platform Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific API CDMO+CMC Service Platform Market Size by Region (2019-2024)
8.4 Asia-Pacific API CDMO+CMC Service Platform Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America API CDMO+CMC Service Platform Market Size (2019-2030)
9.2 Latin America API CDMO+CMC Service Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America API CDMO+CMC Service Platform Market Size by Country (2019-2024)
9.4 Latin America API CDMO+CMC Service Platform Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa API CDMO+CMC Service Platform Market Size (2019-2030)
10.2 Middle East & Africa API CDMO+CMC Service Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa API CDMO+CMC Service Platform Market Size by Country (2019-2024)
10.4 Middle East & Africa API CDMO+CMC Service Platform Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Detail
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group API CDMO+CMC Service Platform Introduction
11.1.4 Lonza Group Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.1.5 Lonza Group Recent Development
11.2 Catalent, Inc.
11.2.1 Catalent, Inc. Company Detail
11.2.2 Catalent, Inc. Business Overview
11.2.3 Catalent, Inc. API CDMO+CMC Service Platform Introduction
11.2.4 Catalent, Inc. Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.2.5 Catalent, Inc. Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific API CDMO+CMC Service Platform Introduction
11.3.4 Thermo Fisher Scientific Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Pfizer CentreOne
11.4.1 Pfizer CentreOne Company Detail
11.4.2 Pfizer CentreOne Business Overview
11.4.3 Pfizer CentreOne API CDMO+CMC Service Platform Introduction
11.4.4 Pfizer CentreOne Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.4.5 Pfizer CentreOne Recent Development
11.5 CordenPharma International
11.5.1 CordenPharma International Company Detail
11.5.2 CordenPharma International Business Overview
11.5.3 CordenPharma International API CDMO+CMC Service Platform Introduction
11.5.4 CordenPharma International Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.5.5 CordenPharma International Recent Development
11.6 Boehringer Ingelheim BioXcellence
11.6.1 Boehringer Ingelheim BioXcellence Company Detail
11.6.2 Boehringer Ingelheim BioXcellence Business Overview
11.6.3 Boehringer Ingelheim BioXcellence API CDMO+CMC Service Platform Introduction
11.6.4 Boehringer Ingelheim BioXcellence Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.6.5 Boehringer Ingelheim BioXcellence Recent Development
11.7 Recipharm AB
11.7.1 Recipharm AB Company Detail
11.7.2 Recipharm AB Business Overview
11.7.3 Recipharm AB API CDMO+CMC Service Platform Introduction
11.7.4 Recipharm AB Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.7.5 Recipharm AB Recent Development
11.8 Changsha Jingyi Pharmaceutical Technology Co., Ltd.
11.8.1 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Company Detail
11.8.2 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Business Overview
11.8.3 Changsha Jingyi Pharmaceutical Technology Co., Ltd. API CDMO+CMC Service Platform Introduction
11.8.4 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.8.5 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Detail
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline API CDMO+CMC Service Platform Introduction
11.9.4 GlaxoSmithKline Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.9.5 GlaxoSmithKline Recent Development
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Detail
11.10.2 Samsung BioLogics Business Overview
11.10.3 Samsung BioLogics API CDMO+CMC Service Platform Introduction
11.10.4 Samsung BioLogics Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.10.5 Samsung BioLogics Recent Development
11.11 Emergent BioSolutions
11.11.1 Emergent BioSolutions Company Detail
11.11.2 Emergent BioSolutions Business Overview
11.11.3 Emergent BioSolutions API CDMO+CMC Service Platform Introduction
11.11.4 Emergent BioSolutions Revenue in API CDMO+CMC Service Platform Business (2019-2024)
11.11.5 Emergent BioSolutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’